A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers
Argonaute
Dicer
DOI:
10.1038/ncomms15622
Publication Date:
2017-05-30T10:30:18Z
AUTHORS (18)
ABSTRACT
Long noncoding RNAs are emerging players in the epigenetic machinery with key roles development and diseases. Here we uncover a complex network comprising promoter-associated RNA (paRNA), microRNA regulators that controls transcription of tumour suppressor E-cadherin epithelial cancers. silencing relies on formation between paRNA microRNA-guided Argonaute 1 that, together, recruit SUV39H1 induce repressive chromatin modifications gene promoter. A single nucleotide polymorphism (rs16260) linked to increased cancer risk alters secondary structure paRNA, allele facilitating assembly silencing. Collectively, these data demonstrate role regulation impact genetic variant its function. Deregulation paRNA-based networks may contribute other diseases making them promising targets for drug discovery.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (77)
CITATIONS (32)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....